{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:56:17Z","timestamp":1792252577110,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023448","name":"Robert Koch Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["1369\\u2013240"],"award-info":[{"award-number":["1369\\u2013240"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijmm.2025.151676","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:40:49Z","timestamp":1758703249000},"page":"151676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Culture-positive COVID-19-associated pulmonary aspergillosis (CAPA) in Germany"],"prefix":"10.1016","volume":"321","author":[{"given":"Leonie H.","family":"Aldejohann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Ruegamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Thielemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kurzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Aldejohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10360","key":"10.1016\/j.ijmm.2025.151676_bib1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in england, Northern Ireland, scotland, and wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijmm.2025.151676_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01689-21","article-title":"Aspergillus lateral flow assay with digital reader for the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a multicenter study","volume":"60","author":"Autier","year":"2022","journal-title":"J. Clin. Microbiol"},{"issue":"2","key":"10.1016\/j.ijmm.2025.151676_bib3","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijmm.2025.151676_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ijmm.2025.151676_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"11","key":"10.1016\/j.ijmm.2025.151676_bib6","article-title":"Risk factors for invasive pulmonary aspergillosis in critically ill patients with coronavirus disease 2019-Induced acute respiratory distress syndrome","volume":"2","author":"Chauvet","year":"2020","journal-title":"Crit. Care Explor"},{"issue":"1","key":"10.1016\/j.ijmm.2025.151676_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2155584","article-title":"Influenza vaccination is associated with a reduced risk of invasive aspergillosis in high-risk individuals in Taiwan: a population-based cohort study","volume":"12","author":"Chen","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.ijmm.2025.151676_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","volume":"50","author":"D'Haese","year":"2012","journal-title":"J. Clin. Microbiol"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02169-21","article-title":"Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?","volume":"60","author":"Delliere","year":"2022","journal-title":"J. Clin. Microbiol"},{"issue":"2","key":"10.1016\/j.ijmm.2025.151676_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jointm.2021.07.001","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"1","author":"Dimopoulos","year":"2021","journal-title":"J. Intensive Med"},{"issue":"12","key":"10.1016\/j.ijmm.2025.151676_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01229-21","article-title":"Aspergillus test profiles and mortality in critically ill COVID-19 patients","volume":"59","author":"Ergun","year":"2021","journal-title":"J. Clin. Microbiol"},{"issue":"1","key":"10.1016\/j.ijmm.2025.151676_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12941-023-00626-7","article-title":"Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study","volume":"22","author":"Estella","year":"2023","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"key":"10.1016\/j.ijmm.2025.151676_bib13","unstructured":"EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs for antifungal agents, version 10.0. 2020."},{"issue":"12","key":"10.1016\/j.ijmm.2025.151676_bib14","article-title":"A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"7","author":"Feys","year":"2021","journal-title":"J. Fungi (Basel)"},{"issue":"9","key":"10.1016\/j.ijmm.2025.151676_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir. Med"},{"issue":"7","key":"10.1016\/j.ijmm.2025.151676_bib16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10096-025-05139-z","article-title":"Fine-tuning FUNDICU: imaging considerations for future research","volume":"44","author":"Feys","year":"2025","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijmm.2025.151676_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijmm.2025.151676_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42057","article-title":"Feasibility of SARS-CoV-2 surveillance testing among children and childcare workers at German day care centers: a nonrandomized controlled trial","volume":"5","author":"Forster","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.ijmm.2025.151676_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02298-21","volume":"60","author":"Giacobbe","year":"2022","journal-title":"J. Clin. Microbiol"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","article-title":"Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"12","author":"Gioia","year":"2024","journal-title":"Lancet Respir. Med"},{"issue":"8","key":"10.1016\/j.ijmm.2025.151676_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ijmm.2025.151676_bib22","unstructured":"Guinea J., Meletiadis J., Arikan-Akdagli S., Giske C., Muehlenthaler K., M.C. Arendrup, et al. EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.4 Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. 2023."},{"issue":"6","key":"10.1016\/j.ijmm.2025.151676_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cmi.2018.09.008","article-title":"How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in aspergillus fumigatus isolates using four-well azole-containing agar plates","volume":"25","author":"Guinea","year":"2019","journal-title":"Clin. Microbiol Infect."},{"issue":"8","key":"10.1016\/j.ijmm.2025.151676_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/08850666211047166","article-title":"Practice guidelines for the diagnosis of COVID-19-associated pulmonary aspergillosis in an intensive care setting","volume":"37","author":"Hashim","year":"2022","journal-title":"J. Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ijmm.2025.151676_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/myc.13443","article-title":"Successful control of candida auris transmission in a German COVID-19 intensive care unit","volume":"65","author":"Hinrichs","year":"2022","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.ijmm.2025.151676_bib26","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijmm.2025.151676_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03142-2021","article-title":"Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study","volume":"59","author":"Koehler","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.ijmm.2025.151676_bib28","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: a systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"issue":"8","key":"10.1016\/j.ijmm.2025.151676_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/00365548.2012.657672","article-title":"Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients","volume":"44","author":"Ku","year":"2012","journal-title":"Scand. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238825","article-title":"Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study","volume":"16","author":"Lahmer","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, risk factors, clinical features, and outcome of influenza-associated pulmonary aspergillosis in critically ill patients: a systematic review and Meta-Analysis","volume":"165","author":"Lu","year":"2024","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijmm.2025.151676_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib33","article-title":"COVID-19 associated invasive pulmonary aspergillosis: diagnostic and therapeutic challenges","volume":"6","author":"Mohamed","year":"2020","journal-title":"J. Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and Corticosteroids-An unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, Multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J. Maxillofac. Oral. Surg."},{"issue":"10","key":"10.1016\/j.ijmm.2025.151676_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00134-021-06471-6","article-title":"Group E-CS. Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a european confederation of medical mycology registry","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ijmm.2025.151676_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the european confederation of medical mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin. Microbiol Infect."},{"key":"10.1016\/j.ijmm.2025.151676_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2022.855914","article-title":"Tracheal aspirate galactomannan testing in COVID-19-associated pulmonary aspergillosis","volume":"3","author":"Roman-Montes","year":"2022","journal-title":"Front Fungal Biol."},{"issue":"10","key":"10.1016\/j.ijmm.2025.151676_bib38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med"},{"issue":"10","key":"10.1016\/j.ijmm.2025.151676_bib39","first-page":"569","article-title":"[Mucormycosis in the time of COVID-19: risks and challenges]","volume":"149","author":"Seidel","year":"2024","journal-title":"Dtsch Med Woche"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad062","article-title":"Risk of coronavirus disease 2019-associated pulmonary aspergillosis based on corticosteroid duration in intensive care patients","volume":"10","author":"Shah","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ijmm.2025.151676_bib41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fmicb.2018.01395","article-title":"Determination of the prevalence of triazole resistance in environmental aspergillus fumigatus strains isolated in south wales, UK","volume":"9","author":"Tsitsopoulou","year":"2018","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.202208-1570OC","article-title":"A Pathology-based case series of Influenza- and COVID-19-associated pulmonary aspergillosis: the proof is in the tissue","volume":"208","author":"Vanderbeke","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"3","key":"10.1016\/j.ijmm.2025.151676_bib43","first-page":"1268","article-title":"The use of bronchoscopy during the coronavirus disease 2019 pandemic","volume":"158","author":"Wahidi","year":"2020","journal-title":"Chest\/AABIP Guidel. Expert Panel Report. Chest"},{"issue":"7","key":"10.1016\/j.ijmm.2025.151676_bib44","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"7798","key":"10.1016\/j.ijmm.2025.151676_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2025.151676_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1287496","article-title":"Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Cell Infect. Microbiol"}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422125000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422125000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:31:25Z","timestamp":1773156685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422125000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S1438422125000323"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2025.151676","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Culture-positive COVID-19-associated pulmonary aspergillosis (CAPA) in Germany","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2025.151676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151676"}}